Impact of occluder device type on success of percutaneous closure of atrial septal defects-a medium-term follow-up study

Journal of Interventional Cardiology

Volumn 22, Issue 6, 2009, Pages 503-510

  Becker, Michael ^a,b   Frings, Dorothee ^a   SchrÖder, Jörg ^a   Ocklenburg, Christina ^a   MÜhler, Eberhard ^a   Hoffmann, Rainer ^a   Franke, Andreas ^c   Lepper, Wolfgang ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c Klinikum Siloah   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; EMBOLISM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATENT FORAMEN OVALE; PRIORITY JOURNAL; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; BALLOON DILATION; CONFIDENCE INTERVALS; EMBOLISM, PARADOXICAL; FEMALE; FORAMEN OVALE, PATENT; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; SEPTAL OCCLUDER DEVICE; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME;

EID: 71149095838     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00507.x     Document Type: Article

References (33)

1. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988 318 (18 1148 1152.
2. Overell JR, Bone I, Lees KR, et al. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000 55 (8 1172 1179.
3. Knauth M, Ries S, Pohimann S, et al. Cohort study of multiple brain lesions in sport divers: Role of a patent foramen ovale. BMJ 1997 314 : 701 705.
4. Gill EA, Jr. Definitions and pathophysiology of the patent foramen ovale: Broad overview. Cardiol Clin 2005 23 : 1 6. (Pubitemid 40164795)
5. Lethen H, Flachskampf FA, Schneider R, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997 80 (8 1066 1069.
6. Hanna JP, Sun JP, Furlan AJ, et al. Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. Stroke 1994 25 (4 782 786.
7. Comess KA, DeRook FA, Beach KW, et al. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: Prevalence of findings and recurrent stroke risk. J Am Cardiol 1994 23 (7 1598 1603.
8. Bogousslavsky J, Garazi S, Jeanrenaud X, et al. G. Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996 46 1301 1305.
9. Stone DA, Godard J, Corretti MC, et al. Patent foramen ovale: Association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996 131 (1 158 161.
10. Mügge A, Daniel WG, Angermann C, et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995 93 (2 398.
11. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001 345 : 1740 1746.
12. Chatterjee T, Petzsch M, Ince H, et al. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism. J Interv Cardiol 2005 18 (3 173 179.
13. Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992 86 : 1902 1908.
14. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events. Circulation 2000 101 (8 893 898.
15. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000 35 (5 1311 1316.
16. Bruch L, Parsi A, Grad M, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism. Circulation 2002 105 : 2845 2848.
17. Slavin L, Tobis J, Rangarajan K, et al. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol 2007 99 : 1316 1320.
18. Sharafuddin MJ, Gu X, Titus JL, et al. Transvenous closure of secundum atrial septal defects: Preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation 1997 95 : 2162 2168.
19. Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002 106 : 1121 1126.
20. Petty GW, Khandheria BK, Chu CP, et al. Patent foramen ovale in patients with cerebral infarction. A transesophageal echocardiographic study. Arch Neurol 1997 54 (7 819 822.
21. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993 24 (12 1865 1873.
22. Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001 345 : 1444 1451.
23. Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997 28 (12 2376 2381.
24. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999 100 : 171 175.
25. Ruchat P, Bogousslavsky J, Hurni M, et al. Systematic surgical closure of patent foramen ovale in selected patients with cerebrovascular events due to paradoxical embolism. Early results of a preliminary study. Eur J Cardiothorac Surg 1997 11 : 824 827.
26. Wahl A, Krumsdorf U, Meier B, et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 2005 45 (3 377 380.
27. Wahl A, Meier B, Haxel B, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001 57 (7 1330 1332. (Pubitemid 32947402)
28. Sievert H, Horvath K, Zadan E, et al. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interv Cardiol 2001 14 : 261 266.
29. Onorato E, Melzi G, Casilli F, et al. Patent foramen ovale with paradoxical embolism: Mid-term results of transcatheter closure in 256 patients. J Interv Cardiol 2003 16 : 43 50.
30. Schwerzmann M, Windecker S, Wahl A, et al. Percutaneous closure of patent foramen ovale: Impact of device design on safety and efficacy. Heart 2004 90 : 186 190.
31. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Peri-procedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004 25 : 424 430.
32. Beitzke A, Schuchlenz H, Beitzke M, et al. Interventional occlusion of foramen ovale and atrial septal defects after paradoxical embolism incidents. Z. Kardiol. 2002 91 : 693 700.
33. Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004 43 : 302 309.